Jefferies Starts Tourmaline Bio (TRML) at Buy
Tweet
Share
E-mailGet Alerts TRML Hot Sheet
Price: $47.98 --0%
Rating Summary:
1 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
1 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
Jefferies analyst Roger Song initiates coverage on Tourmaline Bio (NASDAQ: TRML) with a Buy rating and a price target of $41.00.
For an analyst ratings summary and ratings history on Tourmaline Bio click here. For more ratings news on Tourmaline Bio click here.
Shares of Tourmaline Bio closed at $19.10 yesterday.
You May Also Be Interested In
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
- H.C. Wainwright Assumes Alpha Compute Corp. (ALP) at Neutral
- Wells Fargo Starts Sunbelt Rentals (SUNB) at Overweight
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
